|Minimum Order Quantity||3000 Piece|
|Packaging Size||30 ml|
|Also gives||Third Party Manufacturing|
Ondansetron Oral Solution, USP is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2. initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Ondansetron Oral Solution, USP is also indicated for the prevention of postoperative nausea and/or vomiting.